iBreastExam
A hand-held device cleared by both US FDA and Philippine FDA, iBE detects breast lumps in minutes — no pain, no radiation, no fear. Its 648-sensor Dynamic Co-Planar Capacitive (DCPC) pressure-sensing technology has powered more than 2 million breast exams across 15 countries and is backed by clinical studies involving over 25,000 women. iBE is a step towards bringing accurate, accessible screening for the communities that need it most.
boosting population-based screening initiatives
iBE goes wherever communities need it—no clinics or special facilities required. Fast, scalable, and accessible, the iBE makes large-scale screening possible in places that need it most.
increasing community awareness on breast cancer
Each program with IMOA pairs breast screening with breast health education, encouraging women to come forward and connecting them to care, often for the first time.
strengthening primary care
Designed for simplicity, the iBE puts effective screening directly in the hands of frontline health workers. Alongside clinical breast exams, it sharpens accuracy and helps catch what manual exams alone might miss.
